← Leaderboards
Tariq M Rana
Univ Of Med/Dent Nj-R W Johnson Med Sch
$51,311,096
Attributed
$55,028,585
Total exposure
21
Grants
18
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.5M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$55,028,585 · 21
By mechanism
R01$20,502,591 · 7
U01$18,632,060 · 2
P01$6,538,631 · 3
DP1$3,867,250 · 1
U19$1,828,523 · 1
R56$1,455,111 · 2
Top collaborators
- Shilpa J Buch3 shared
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsMolecularPharmaceutical PreparationsViralInfectionHiv-1InsightGenesProteinsStructureBaseComplexImmuneAcquired Immunodeficiency SyndromeProgramsBiologyHiv InfectionsPlayLife Cycle StagesGenetic TranscriptionVirusEnzymesVirus DiseasesGene Expression
Grant awards (100)
Single cell determinants of brain in the context of viral persistence in SIV/cART/cocaine non-human primates$2,467,417
U01 · FY2025 · DA · contact PI
Revealing the single cell determinants of brain relevant to persistent HIV infection and opioid use disorder$2,227,239
U01 · FY2025 · DA · contact PI
Single cell determinants of brain in the context of viral persistence in SIV/cART/cocaine non-human primates$2,473,493
U01 · FY2024 · DA · contact PI
Revealing the single cell determinants of brain relevant to persistent HIV infection and opioid use disorder$2,233,422
U01 · FY2024 · DA · contact PI
Role of PCIF1 in Regulating Host-HIV interactions$502,861
R56 · FY2024 · AI · contact PI
Single cell determinants of brain in the context of viral persistence in SIV/cART/cocaine non-human primates$2,494,069
U01 · FY2023 · DA · contact PI
Revealing the single cell determinants of brain relevant to persistent HIV infection and opioid use disorder$2,239,465
U01 · FY2023 · DA · contact PI
Investigating the molecular mechanisms of HIV/AIDS associated neurological disorders using microglia and cerebral organoids derived from induced pluripotent stem cells$782,711
R01 · FY2023 · DA · contact PI
Revealing the single cell determinants of brain relevant to persistent HIV infection and opioid use disorder$2,245,174
U01 · FY2022 · DA · contact PI
Investigating the molecular mechanisms of HIV/AIDS associated neurological disorders using microglia and cerebral organoids derived from induced pluripotent stem cells$782,711
R01 · FY2022 · DA · contact PI
Identification and Regulation of RNA Modification by HIV infection and Methamphetamine$615,921
R01 · FY2022 · DA · contact PI
Revealing the single cell determinants of brain relevant to persistent HIV infection and opioid use disorder$2,251,781
U01 · FY2021 · DA · contact PI
Investigating the molecular mechanisms of HIV/AIDS associated neurological disorders using microglia and cerebral organoids derived from induced pluripotent stem cells$782,711
R01 · FY2021 · DA · contact PI
Identification and Regulation of RNA Modification by HIV infection and Methamphetamine$616,135
R01 · FY2021 · DA · contact PI
Investigating the molecular mechanisms of HIV/AIDS associated neurological disorders using microglia and cerebral organoids derived from induced pluripotent stem cells$780,441
R01 · FY2020 · DA · contact PI
Modeling HIV/AIDS Associated Neurological Disorders with Human Pluripotent Cells$775,000
DP1 · FY2020 · DA · contact PI
Identification and Regulation of RNA Modification by HIV infection and Methamphetamine$616,347
R01 · FY2020 · DA · contact PI
m6A-RNA demethylase ALKBH5 inhibitors for the treatment of glioblastoma$433,813
R21 · FY2020 · NS · contact PI
Investigating the molecular mechanisms of HIV/AIDS associated neurological disorders using microglia and cerebral organoids derived from induced pluripotent stem cells$780,235
R01 · FY2019 · DA · contact PI
Identification and Regulation of RNA Modification by HIV infection and Methamphetamine$616,551
R01 · FY2019 · DA · contact PI
Modeling HIV/AIDS Associated Neurological Disorders with Human Pluripotent Cells$775,000
DP1 · FY2018 · DA · contact PI
Identification and Regulation of RNA Modification by HIV infection and Methamphetamine$630,504
R01 · FY2018 · DA · contact PI
Role of Non-Coding RNAs in Regulating Gamma-Herpesvirus-Host-Interactions$393,176
P01 · FY2018 · CA · contact PI
Vif Antagonism: Lead Discovery and SAR - Project 1$1,048,792
P01 · FY2017 · MH · contact PI
Modeling HIV/AIDS Associated Neurological Disorders with Human Pluripotent Cells$775,000
DP1 · FY2017 · DA · contact PI
Role of Non-Coding RNAs in Regulating Gamma-Herpesvirus-Host-Interactions$393,178
P01 · FY2017 · CA · contact PI
Regulation of HIV-1 Replication by Cellular IncRNAs$193,750
R21 · FY2017 · AI · contact PI
Modeling HIV/AIDS Associated Neurological Disorders with Human Pluripotent Cells$767,250
DP1 · FY2016 · DA · contact PI
Vif Antagonism: Lead Discovery and SAR - Project 1$408,792
P01 · FY2016 · MH · contact PI
Role of Non-Coding RNAs in Regulating Gamma-Herpesvirus-Host-Interactions$393,178
P01 · FY2016 · CA · contact PI
Regulation of HIV-1 Replication by Cellular IncRNAs$232,500
R21 · FY2016 · AI · contact PI
Modeling HIV/AIDS Associated Neurological Disorders with Human Pluripotent Cells$775,000
DP1 · FY2015 · DA · contact PI
Vif Antagonism: Lead Discovery and SAR - Project 1$408,792
P01 · FY2015 · MH · contact PI
Role of Non-Coding RNAs in Regulating Gamma-Herpesvirus-Host-Interactions$386,511
P01 · FY2015 · CA · contact PI
Role of Non-Coding RNAs in Regulating Gamma-Herpesvirus-Host-Interactions$443,015
P01 · FY2014 · CA · contact PI
Vif Antagonism: Lead Discovery and SAR - Project 1$408,792
P01 · FY2014 · MH · contact PI
Regulation of HIV infection by Methamphetamine and non-coding RNAs$399,750
R01 · FY2014 · DA · contact PI
Mechanisms of innate immunity against HIV$359,600
R01 · FY2014 · AI · contact PI
FUNCTIONAL GENOMICS$178,569
P30 · FY2014 · CA · contact PI
Regulation of HIV infection by Methamphetamine and non-coding RNAs$91,223
R01 · FY2014 · DA · contact PI
Mechanisms of innate immunity against HIV$30,225
R01 · FY2014 · AI · contact PI
Regulation of HIV infection by Methamphetamine and non-coding RNAs$481,467
R01 · FY2013 · DA · contact PI
Mechanisms of innate immunity against HIV$453,668
R01 · FY2013 · AI · contact PI
Vif Antagonism: Lead Discovery and SAR$422,167
P01 · FY2013 · MH · contact PI
Structure and Function of Ribonucleoprotein Complexes Modulating HIV Replication$320,881
R01 · FY2013 · AI · contact PI
FUNCTIONAL GENOMICS$199,813
P30 · FY2013 · CA · contact PI
Structure and Function of Ribonucleoprotein Complexes Modulating HIV Replication$50,018
R01 · FY2013 · AI · contact PI
Regulation of HIV infection by Methamphetamine and non-coding RNAs$520,783
R01 · FY2012 · DA · contact PI
Mechanisms of innate immunity against HIV$472,725
R01 · FY2012 · AI · contact PI
Structure and Function of Ribonucleoprotein Complexes Modulating HIV Replication$472,725
R01 · FY2012 · AI · contact PI
VIF anatagonist: lead Inhibitor Identification$344,614
U19 · FY2012 · MH · contact PI
FUNCTIONAL GENOMICS$189,125
P30 · FY2012 · CA · contact PI
FUNCTIONAL GENOMICS$7,938
P30 · FY2012 · CA · contact PI
Regulation of HIV infection by Methamphetamine and non-coding RNAs$529,081
R01 · FY2011 · DA · contact PI
Mechanisms of innate immunity against HIV$472,725
R01 · FY2011 · AI · contact PI
Structure and Function of Ribonucleoprotein Complexes Modulating HIV Replication$472,725
R01 · FY2011 · AI · contact PI
VIF anatagonist: lead Inhibitor Identification$355,295
U19 · FY2011 · MH · contact PI
Design, Synthesis and Biological Evaluation of HIV-1 Protease Inhibitor Libraries$350,887
P01 · FY2011 · GM · contact PI
FUNCTIONAL GENOMICS$89,249
P30 · FY2011 · CA · contact PI
Regulation of HIV infection by Methamphetamine and non-coding RNAs$539,848
R01 · FY2010 · DA · contact PI
RNAi-Based Therapy of ALS$507,034
R01 · FY2010 · NS · contact PI
Structure and Function of Ribonucleoprotein Complexes Modulating HIV Replication$477,500
R01 · FY2010 · AI · contact PI
Mechanisms of innate immunity against HIV$477,500
R01 · FY2010 · AI · contact PI
Design, Synthesis and Biological Evaluation of HIV-1 Protease Inhibitor Libraries$356,415
P01 · FY2010 · GM · contact PI
FUNCTIONAL GENOMICS$94,932
P30 · FY2010 · CA · contact PI
RNAi-Based Therapy of ALS$527,212
R01 · FY2009 · NS · contact PI
Structure and Function of Ribonucleoprotein Complexes Modulating HIV Replication$474,750
R56 · FY2009 · AI · contact PI
VIF anatagonist: lead Inhibitor Identification$404,182
U19 · FY2009 · MH · contact PI
Design, Synthesis and Biological Evaluation of HIV-1 Protease Inhibitor Libraries$351,529
P01 · FY2009 · GM · contact PI
Structure and Function of Ribonucleoprotein Complexes Modulating HIV Replication$477,500
R56 · FY2008 · AI · contact PI
Design, Synthesis and Biological Evaluation of HIV-1 Protease Inhibitor Libraries$343,289
P01 · FY2008 · GM · contact PI
VIF anatagonist: lead Inhibitor Identification$326,307
U19 · FY2008 · MH · contact PI
Design, Synthesis and Biological Evaluation of HIV-1 Protease Inhibitor Libraries$430,118
P01 · FY2007 · GM · contact PI
VIF anatagonist: lead Inhibitor Identification$398,125
U19 · FY2007 · MH · contact PI
Dynamics of Transcriptional Activation in HIV$339,212
R01 · FY2007 · AI · contact PI
Structure and Function of HIV Tat-TAR Complex$388,159
R01 · FY2006 · AI · contact PI
Dynamics of Transcriptional Activation in HIV$349,344
R01 · FY2006 · AI · contact PI
Structure and Function of HIV Tat-TAR Complex$397,500
R01 · FY2005 · AI
Dynamics of Transcriptional Activation in HIV$357,750
R01 · FY2005 · AI
Structure and Function of HIV Tat-TAR Complex$397,500
R01 · FY2004 · AI
Dynamics of Transcriptional Activation in HIV$357,750
R01 · FY2004 · AI
Structure and Function of HIV Tat-TAR Complex$397,500
R01 · FY2003 · AI
TARGETING HIV VIF PROTEIN$238,500
R21 · FY2003 · AI
Dynamics of Transcriptional Activation in HIV$178,875
R01 · FY2003 · AI
Structure and Function of HIV Tat-TAR Complex$397,500
R01 · FY2002 · AI
INHIBITION OF HIV REPLICATION$318,000
R01 · FY2002 · AI
DYNAMICS OF TRANSCRIPTIONAL ACTIVATION IN HIV$270,998
R01 · FY2002 · AI
TARGETING HIV VIF PROTEIN$238,500
R21 · FY2002 · AI
Core--Combinatorial libraries synthesis and screening$0
P01 · FY2002 · GM
INHIBITION OF HIV REPLICATION$279,462
R01 · FY2001 · AI
STRUCTURE/FUNCTION OF HIV TAT-TAR COMPLEX$241,494
R01 · FY2001 · AI
DYNAMICS OF TRANSCRIPTIONAL ACTIVATION IN HIV$129,957
R01 · FY2001 · AI
DYNAMICS OF TRANSCRIPTIONAL ACTIVATION IN HIV$128,521
R01 · FY2001 · AI
STRUCTURE/FUNCTION OF HIV TAT-TAR COMPLEX$35,622
R01 · FY2001 · AI
INHIBITION OF HIV REPLICATION$34,538
R01 · FY2001 · AI
INHIBITION OF HIV REPLICATION$296,900
R01 · FY2000 · AI
STRUCTURE/FUNCTION OF HIV TAT-TAR COMPLEX$269,044
R01 · FY2000 · AI
DYNAMICS OF TRANSCRIPTIONAL ACTIVATION IN HIV$255,709
R01 · FY2000 · AI
PROBING TAT TAR INTERACTIONS IN HIV BY CHEMICAL METHODS$107,730
K02 · FY2000 · AI
DYNAMICS OF TRANSCRIPTIONAL ACTIVATION IN HIV$20,299
R01 · FY2000 · AI